Curium us llc

Index
Globenewswire

Curium’s Investigational New Drug Application Accepted by Center for Drug Evaluation in China

Globenewswire

Curium Establishes Legal Entity in China

Globenewswire

CapVest Recapitalizes Curium to Accelerate its Growth Strategy, Marking the Largest Transaction in Nuclear Medicine Globally

Globenewswire

Curium Consolidates New Biopharma Business and Sets Up Global Headquarters in Boston, Massachusetts

Globenewswire

Curium Group, PeptiDream and PDRadiopharma Enroll First Patient to Registrational Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan

Globenewswire

Curium and NRG PALLAS Extend Collaboration in the Supply of Essential Medical Isotope to Hospitals

Globenewswire

Curium Menyelesaikan Akuisisi Monrol sebagai Bagian dari Rencananya untuk Secara Signifikan Meningkatkan Kapasitas Lutetium-177 dan Jaringan PET

Globenewswire

Curium Completes the Acquisition of Monrol as Part of its Plan to Significantly Expand Lutetium-177 Capacity and PET Footprint

Globenewswire

Curium Announces ECLIPSE Trial Has Met Primary Endpoint, Demonstrating a Statistically Significant and Clinically Meaningful Benefit for Patients With PSMA-Positive Metastatic Castration Resistant Prostate Cancer

Globenewswire

Curium Mengumumkan Kemitraan Strategis dengan PeptiDream untuk Teranostik Kanker Prostat di Jepang

Globenewswire

Curium Announces Strategic Partnership with PeptiDream for Prostate Cancer Theranostics in Japan

Globenewswire

Curium Announces First Patients in Europe Injected With PYLCLARI® – an Innovative 18F-PSMA Pet Tracer Indicated in Patients With Prostate Cancer

Globenewswire

Curium and PIUR IMAGING Announce Thyroid Imaging Partnership in Germany to Enable Tomographic 3D Ultrasound Solutions